| BioID | bio2947 |
| Name | DARIFENACIN HYDROBROMIDE |
| ChEMBL ID | CHEMBL1200935 |
| Molecular Formula | C28H31BrN2O2 |
| Molecular Weight | 507.47 |
| Molecular Weight (Monoisotopic) | 426.2307 |
| Type | Small molecule |
| Max Phase | Phase 4 |
| Target ID | Tar12 |
| Target Name | Toll-like receptor 9 (TLR9) |
| Synonyms | DARIFENACIN HBR|DARIFENACIN HYDROBROMIDE|ENABLEX|Emselex|UK-88525-04 (HBR)|UK-88525-04 (HYDROBROMIDE) |
| Smiles | Br.NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1 |
| Inchi | InChI=1S/C28H30N2O2.BrH/c29-27(31)28(23-7-3-1-4-8-23,24-9-5-2-6-10-24)25-14-17-30(20-25)16-13-21-11-12-26-22(19-21)15-18-32-26;/h1-12,19,25H,13-18,20H2,(H2,29,31);1H/t25-;/m1./s1 |
| Inchi Key | UQAVIASOPREUIT-VQIWEWKSSA-N |
| Molecular Species | BASE |
| Targets | 7.0 |
| Bioactivities | 87.0 |
| Np Likeness Score | -0.56 |
| Records Key | ['SID170465079', 'DARIFENACIN HYDROBROMIDE', 'DARIFENACIN HYDROBROMIDE', 'DARIFENACIN HYDROBROMIDE', 'Darifenacin hydrobromide', 'DARIFENACIN HYDROBROMIDE', 'SID144206189', 'DARIFENACIN HYDROBROMIDE', 'DARIFENACIN HYDROBROMIDE', 'DARIFENACIN HYDROBROMIDE', 'DARIFENACIN HYDROBROMIDE', 'DARIFENACIN HYDROBROMIDE', 'EOS101748', 'DARIFENACIN HYDROBROMIDE'] |
| Records Name | ['SID170465079', 'DARIFENACIN HYDROBROMIDE', 'DARIFENACIN HYDROBROMIDE', 'DARIFENACIN HYDROBROMIDE', 'Darifenacin hydrobromide', 'DARIFENACIN HYDROBROMIDE', 'SID144206189', 'DARIFENACIN HYDROBROMIDE', 'DARIFENACIN HYDROBROMIDE', 'DARIFENACIN HYDROBROMIDE', 'DARIFENACIN HYDROBROMIDE', 'DARIFENACIN HYDROBROMIDE', 'Darifenacin (hydrobromide)', 'DARIFENACIN HYDROBROMIDE'] |
| Withdrawn Flag | False |
| Orphan | 0 |